Healthwell Acquisition Corp. I
HWELU
NASDAQ Capital Market10.46
USD
+0.01
- -
CIK
0001845013
Return %
Stock
S&P500
1Y
4.29
26.84
3Y
5.66
77.03
5Y
5.66
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Alyssa J. Rapp
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 1001 Green Bay Road Winnetka IL United States of America 60093
- IPO Date
- Aug 3, 2021
- CIK
- 0001845013
- Similar Companies
- Business
- Healthwell Acquisition Corp. I (Nasdaq: HWELU) is a blank check company that focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, with a strategic emphasis on technology-enabled companies in the healthcare industry; it offers no current products or services beyond its special purpose acquisition structure, including units comprising common stock and warrants held in trust for deployment in a target combination. Incorporated in 2021 and headquartered in Winnetka, Illinois, the company operates as a subsidiary of Healthwell Acquisition Corp. I Sponsor LLC and maintains its primary activities in the United States without specified international geographic operations or additional segments beyond its pre-combination phase. In April 2023, it entered a definitive business combination agreement with Starton Therapeutics, Inc., targeting a post-transaction enterprise value of $339 million to advance proprietary continuous delivery technologies for cancer treatments including multiple myeloma and chronic lymphocytic leukemia; the transaction terminated in November 2023 as closing conditions were unmet by the outside date, prompting Healthwell to pursue alternative combinations, followed by a redemption of public shares in late 2023 with no further merger announcements as of late 2025.
U.S. IPO Weekly Recap: Postponements Abound In A 4 IPO Week